News

Ark Therapeutics, a specialist healthcare company, has announced that the first named patient supply for Cerepro has been approved by the French Medicines Control Agency following a ‘nominative’

Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical, a member of the Roche Group, have entered into an exclusive licensing agreement for the development and commercialisation

In addition to this capacity, Sheares was a member of Merck’s management committee, which was responsible for formulating global business strategies, managing operations and setting corporate policies. He

The company reported fourth quarter 2008 revenue of $26.7 million, up 22% over revenue of $21.9 million in the fourth quarter of 2007, and record full year revenue

Mr Longhini joined the company in 2003 as executive vice president and chief technology officer and in 2006 was promoted to executive vice president and COO. Mr Longhini

The price to be paid for the common stock, $7.13 per share, is equal to the consolidated closing bid price on the Nasdaq global market on the day

Sanofi Pasteur is collaborating with Mahidol University of Thailand, the Ministry of Public Health, and the Pediatric Dengue Vaccine Initiative to conduct this efficacy study in the province

This important invention is one of several innovative technological advances incorporated in the new DuraMAX side firing fiber developed by Trimedyne. This new fiber will be marketed by

The company has reported revenue of $3.5 billion in the third quarter of fiscal year 2009, a 3% increase, compared to $3.4 billion in same period of fiscal